UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark  One)
[X]  Quarterly  report  under Section 13 or 15(d) of the Securities Exchange Act
     of  1934  for  the  quarterly  period  ended  August  31,  2000.

[  ]  Transition report under Section 13 or 15(d) of the Securities Exchange Act
      of 1934 (No fee required) for the transition period from  _____________ to
 _______________.

                         Commission file number 2-90519

                           CENTURY LABORATORIES, INC.
                 (Name of small business issuer in its charter)

          Delaware                                               72-0510027
(State  or  other  jurisdiction  of                           (I.R.S. Employer
 incorporation  or  organization)                            Identification No.)

                                 730 2nd Street
                            Santa Rosa, CA 95402-3588
               (Address of principal executive offices) (Zip Code)

                    Issuer's telephone number: (707)935-6945

Check  whether  the issuer: (1)filed all reports required to be filed by Section
13  or  15(d) of the Exchange Act during the past 12 months (or for such shorter
period  that the registrant was required to file such reports), and (2) has been
subject  to  such  filing  requirements  for  the  past  90  days.

                           Yes  [  ]         No  [X]

The number of shares outstanding of Registrant's common stock ($0.001 par value)
as  of the quarter ended August 31, 2000 and, as of the latest practicable date,
August  31,  2000,  is  10,000,000.


<PAGE>



                                TABLE  OF  CONTENTS

                                     PART  1

                                                                          Page

ITEM  1.  FINANCIAL  STATEMENTS -----------------------------------------  4

ITEM  2.  MANAGEMENT'S  DISCUSSION
          AND  ANALYSIS  OR  PLAN  OF  OPERATION ------------------------ 11


                                     PART  II

ITEM  5.  OTHER --------------------------------------------------------- 11

ITEM  6.  EXHIBITS  AND  REPORTS  ON  FORM  8-K ------------------------- 12

          SIGNATURES ---------------------------------------------------- 13


<PAGE>


                                     PART  I
-------------------------------
ITEM  1.  FINANCIAL  STATEMENTS
-------------------------------
         Unless  otherwise  indicated,  the  term  "Company"  refers  to Century
Laboratories,  Inc.  and  its  subsidiaries  and predecessors.  The accompanying
consolidated  unaudited  condensed  financial  statements  have been prepared by
management in accordance with the instructions in Form 10-QSB and, therefore, so
not  include  all  information  and  footnotes  required  by  generally accepted
accounting  principals  and  should,  therefore,  be  read  in  conjunction with
Company's Annual Report to Shareholders on Form 10-KSB for the fiscal year ended
May  31, 2000.  These statements do include all the normal recurring adjustments
which  the  Company  believes is necessary and affords a fair presentation.  The
interim  results are not necessarily indicative of the results for the full year
ending  May  31,  2001.  Accordingly,  consolidated  audited  interim  financial
statements,  including  a balance sheet for the Company as of the fiscal quarter
ended  August  31,  2000,  and,  statements of operations and statements of cash
flows  for  the  interim  period  up  to  the date of such balance sheet and the
comparable  period of the preceding fiscal year are attached hereto as Pages F-1
through  F-6  and  are  incorporated  herein  by  this  reference.


<PAGE>






                              FINANCIAL STATEMENTS



            FOR THE PERIODS ENDED AUGUST 31, 2000 AND AUGUST 31 1999






<PAGE>


                                   DAVID SUSS
                           CERTIFIED PUBLIC ACCOUNTANT
                               271 MADISON AVENUE
                                    SUITE 208
                              NEW YORK, N.Y. 10016
                                 (212) 883-1050

Board  of  Directors
Century  Laboratories,  Inc.

                          INDEPENDENT AUDITORS' REPORT
                          ----------------------------

I  have audited the accompanying balance sheets of Century Laboratories, Inc. as
of  August  31,  2000,  and  August  31,  1999,  and  the  related statements of
operations, cash flows and stockholders' equity for the years then ended.  These
financial statements are the responsibility of management.  My responsibility is
to  express  an  opinion  on  these  financial  statements  based on our audits.

I  conducted  my  audit in accordance with generally accepted audited standards.
Those standards require that we plan and perform the audits to obtain reasonable
assurance  about  whether  the  financial  statements  are  free  of  material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing  the  accounting  principles  used  and  significant estimates made by
management,  as well as evaluating the overall financial statement presentation.
I  believe  that  my  audit  provides  a  reasonable  basis  for  my  opinion.

The  accompanying  financial  statements  have  been  prepared assuming that the
Company  will  continue  as  a  going  concern.  As  discussed  in Note 1 to the
financial statements, the Company has no viable operations or significant assets
and  is  dependent  upon  its president to provide sufficient working capital to
maintain  the  integrity  of  the  corporate  entity   The  circumstances create
substantial doubt about the Company's ability to continue as a going concern and
are  discussed  in  Note  1.  The  financial  statements  do  not  contain  any
adjustments  that  might  result  from  the  outcome  of  these  uncertainties.

In my opinion, the financial statements referred to above present fairly, in all
material  respects,  the  financial position of Century Laboratories, Inc. as of
August 31, 2000, and August 31, 1999, and the results of its operations and cash
flows  for the years then ended in conformity with generally accepted accounting
principles.

/s/_________________
David  Suss,  CPA

September  11,  2000


<PAGE>


<TABLE>
<CAPTION>


                           CENTURY LABORATORIES, INC.

                           CONSOLIDATED BALANCE SHEET
                           --------------------------

                                     AUDITED
                                     -------


                                                    ASSETS
                                              -------------------
                                          August 31,           August 31,
                                            2000                 1999
                                     -------------------  ------------------
<S>                                         <C>                  <C>
Cash                                 $                0   $               0

Fixed Assets:
-------------
Office Equipment                                  2,395                   0
                                     -------------------  ------------------
Total Assets                                      2,395                   0
                                     ===================  ==================

                     LIABILITIES AND SHAREHOLDER EQUITY
                     -----------------------------------

Liabilities:
-------------
Accounts Payable
   Note 3                            $                0   $          19,500
                                     -------------------  ------------------

   Total Liabilities                 $                0   $          19,500
                                     -------------------  ------------------

Shareholders' Equity:
---------------------
Common Stock, $.01 par value
   per share; 10,000,000 shares
   authorized, 5,233,594 shares
   issued and outstanding 8/31/99
   9,999,986 shares issued and
   outstanding 8/31/2000                        100,000              52,336

Additional Paid-in Capital                    7,440,110           7,287,774

Retained Earnings (Deficit)                  (7,537,715)         (7,359,610)
                                     -------------------  ------------------

Total Shareholders' Equity
   (Deficit)                              (       2,395)       (     19,500)
                                     -------------------  ------------------

Total Liabilities and
   Shareholders' Equity              $            2,395   $               0
                                     ===================  ==================

</TABLE>


<PAGE>


<TABLE>
<CAPTION>


                           CENTURY LABORATORIES, INC.

                        STATEMENT OF STOCKHOLDERS' EQUITY
                        ---------------------------------

                                          Additional    Retained
                        Common Stock        Paid-In     Earnings
                    Shares       Amount     Capital     (Deficit)
                 -------------  ---------  ----------  -------------
<S>                    <C>         <C>        <C>          <C>

Balance
   May 31, 1997  $   4,840,094  $  48,401  $7,142,709   ($7,359,610)

Stock Issued           393,500      3,935     145,064

Balance
   May 31, 1998      5,233,594     52,336   7,287,774    (7,359,610)

Balance
   May, 31 1999      5,233,594     52,336   7,287,774    (7,359,610)

Net Income                                                    9,297

Balance
   May 31, 2000      5,233,594     52,336   7,287,774    (7,350,313)

Common Stock
   Issued            4,766,392     47,664     152,356

Net Loss                                                   (187,402)
                                                       -------------

BALANCE
   8/31/00       $   9,999,986  $ 100,000  $7,440,110  $ (7,537,715)
                 =============  =========  ==========  =============
</TABLE>


<PAGE>


<TABLE>
<CAPTION>


                           CENTURY LABORATORIES, INC.

                      CONSOLIDATED STATEMENT OF OPERATIONS
                      ------------------------------------

                                     AUDITED
                                     -------



                                       Three Months Ended
                                      --------------------
                                August 31, 2000     August 31, 1999
                              --------------------  ----------------
<S>                                   <C>                   <C>
Revenue                       $                 0   $              0

Expenses:
----------------------------

Consulting Fee                            194,991                  0

Professional Fees                             725                  0

Regulatory Expense                            349                  0

Travel and Entertaining                       119                  0

Office Expense                                701                  0

Shareholders Expense                          473                  0

Franchise Tax                                 496                  0
                              --------------------  ----------------

                              $           197,404                  0

Non-Recurring Income:
----------------------------

Accounts Payable Write-Off                 10,002                  0
                              --------------------  ----------------

Net Loss                                 (187,402)                 0

Weighted Average Number of
   Common Shares Outstanding            9,999,986          5,233,594
                              ====================  ================

</TABLE>


<PAGE>


<TABLE>
<CAPTION>


                           CENTURY LABORATORIES, INC.

                      CONSOLIDATED STATEMENT OF CASH FLOWS
                      ------------------------------------
                                     AUDITED
                                     -------

                                                For the Three Months Ended
                                               ----------------------------
                                           August 31, 2000       August 31, 1999
                                           ---------------       ----------------
<S>                                              <C>              <C>

Cash Flows from
   Operating Activities                   $      (187,402)  $              0

Decrease in Accounts Payable                       10,000                  0

Sale of Common Stock                              200,000                  0

Decrease in Due to
   Shareholder                                     (2,596)                 0

Total Cash Flows                                        0                  0

Cash at Beginning                                   2,570                  0

Decrease in Cash                                    2,570                  0
                              ----------------------------  ----------------

Cash at End of Period                    $              0   $              0
                                          ================    ==============
</TABLE>


<PAGE>


                           CENTURY LABORATORIES, INC.

                          NOTES TO FINANCIAL STATEMENTS
                          -----------------------------

1.     ORGANIZATION  AND  DESCRIPTION  OF  BUSINESS

     Century  Laboratories,  Inc.  (the  "Company")  is  an  inactive  Delaware
corporation.  Century Laboratories, Inc. was originally incorporated as Carrtone
Laboratories,  Inc.  in  1958  under  the  laws of the state of Delaware. During
fiscal  year  1994, the Company had its charter revoked by the State of Delaware
for  failure  to  file  franchise  tax reports and pay the required taxes and/or
fees.

     A  certificate  of  renewal  and  revival  of  its charter of incorporation
pursuant  to Section 312 of the General Corporation Law of the State of Delaware
was  filed.  As a result, the charter of the corporation was reinstated in March
1999.

2.     STOCKHOLDERS'  EQUITY

     The  Company  issued  393,500  shares of common stock in February 1996.  Of
those  shares,  149,000 shares were issued to settle unpaid professional fees of
$149,000  and 224,500 shares were issued to the Company's president for services
rendered.  4,766,392  shares  were  issued  for  $200,000  cash.

3.     Management has written off the A/C payable as these liabilities are prior
to  1992.

4.     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES

     Significant  Credit  Risk  and  Estimates:
     -----------------------------------------

     Management  of  the  Company  uses  estimates  and assumptions in preparing
financial  statements  in  accordance  with  generally  accepted  accounting
principles.  Those  estimates  and  assumptions  affect  the reported amounts of
assets and liabilities, the disclosure of contingent assets and liabilities, and
the  reported revenue and expenses. Actual results could vary from the estimates
that  management  uses.

<PAGE>

----------------------------------------------
ITEM  2.   MANAGEMENT'S  DISCUSSION  AND  ANALYSIS
----------------------------------------------

     The  following  discussion  and analysis should be read in conjunction with
the  Company  financial  statements and notes thereto included elsewhere in this
Form  10-QSB.  Except  for  the  historical  information  contained  herein, the
discussion  in this Form 10-QSB contains certain forward looking statements that
involve  risks  and  uncertainties,  such  as  statements of the Company  plans,
objectives, expectations and intentions.  The cautionary statements made in this
Form 10-QSB should be read as being applicable to all related forward statements
wherever  they  appear  in  this  Form 10-QSB.  The Company actual results could
differ  materially  from  those  discussed  here.

     Other than what has been disclosed herein and in the quarterly reports from
the  quarter  ended  August  31, 2000, the Company is not aware of any immediate
circumstances  or trends which would have a negative impact upon future sales or
earnings.  There  have  been  no  material fluctuations in the standard seasonal
variations  of  the  Company  business.  The  accompanying  financial statements
include  all  adjustments,  which  in the opinion of management are necessary in
order  to  make  the  financial  statements  not  misleading.

Results  of  Operations.

     For  the  quarter  ended  August  31,  2000,  the  Company sustained a loss
of $187,402.  The loss can be contributed to unsettled professional fees and for
services  rendered.  For  the  comparable  period  of  1999,  the Company had no
revenues  and  sustained  a  loss  of  $0.00.  The  Company  had a deficiency of
stockholder's  equity of $2,395 at August 31, 2000 compared to $19,500 in August
31,  1999.

                                     PART II

-------------------------------
ITEM  2.  CHANGES IN SECURITIES
-------------------------------

     On  July  3, 2000, the Company entered into a Stock Purchase Agreement with
Robert  Bryan,  whereupon,  among  other  things,  Robert  Bryan and/or Assigns,
acquired  4,766,320  of  newly  issued  shares  of  the  Company's  common stock
resulting  in  10,000,000  shares  being  issued  and outstanding, in return for
$200,000  or,  at a price of $0.042 per share.  This transaction was consummated
on  July  21,  2000.

     On  August  21,  the Company increased its authorized number of shares from
10,000,000 shares of common stock to 65,000,000 shares of common stock at $0.001
par  value  and,  1,000,000  shares  of  preferred stock to 10,000,000 shares of
preferred  stock  at  $0.001  par  value.

     On  November  27,  2000, the Company enacted a 20 to 1 stock reverse split.
The  Corporation  believes that it is necessary to effectuate this reverse split
in order to avoid the continued depression of the Corporation's stock price and,
in  order  to  secure  financing  which  must be obtained for the Corporation to
continue  to  exist  as  a  going  concern. Prior to the 20:1 reverse split, the
Company  had  10,000,000 shares issued and outstanding.  As a result of the 20:1
reverse  split,  the  Company  now  has  500,000  shares issued and outstanding.

     On August 18, 2000, Edwin Mendlinger resigned as President, Vice-President,
Treasurer  and  Director  of  the  Company.  On  August  18,  2000, Louis Birner
resigned  as  Secretary  and  Director  of  the  Company.

     On  August  18,  2000,  Robert  Bryan  was  appointed  as  President,
Vice-President,  Treasurer,  Secretary  and  Director  of  the  Company.

-----------------------------------------
ITEM 5 OTHER
-----------------------------------------
  SUBSEQUENT  EVENTS

     On  December  19, 2000 the Company changed its fiscal year end from May 31.
to  December  31.

-----------------------------------------
ITEM  6.  EXHIBITS  AND  REPORTS  ON  FORM  8-K
-----------------------------------------

 Exhibit    Exhibit
 Number     Description
________    ________________________________________________________
   3.1      Certificate  of  Amendment  of  Incorporation  from  the  State  of
            Delaware

   3.2      Consent  to  change  of  fiscal  year

   4        Resolution  increasing  authorization  of  shares

   4.1      Resolution  authorizing  reverse  split

   10       Stock  Purchase  Agreement

   10.1     Amendment  to  Stock  Purchase  Agreement

   17       Resignation  of  officers  and  directors

   17.1     Appointment  of  Officers  and  Directors

   27       Financial  Data  Schedule


                                   SIGNATURES
     In  accordance with Section 13 or 15(d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized  this  20th  day  of  December,  2000.

         CENTURY  LABORATORIES,  INC.

         /s/  Robert  Bryan
         -------------------------
         Robert  Bryan,  President

     In  accordance  with the Exchange Act, this report has been signed below by
the  following  persons on behalf of the registrant and in the capacities and on
the  dates  indicated.

Signature                           Title                          Date
---------                           -----                          ----

/s/Robert  Bryan             President,  Secretary           December  20, 2000
----------------             Treasurer  and  Director